Amalgamated Bank Has $691,000 Stake in Addus HomeCare Co. (NASDAQ:ADUS)

Amalgamated Bank decreased its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 2.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,195 shares of the company’s stock after selling 135 shares during the period. Amalgamated Bank’s holdings in Addus HomeCare were worth $691,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Texas Permanent School Fund Corp increased its holdings in Addus HomeCare by 0.6% in the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock worth $1,636,000 after buying an additional 82 shares during the last quarter. Arizona State Retirement System increased its holdings in Addus HomeCare by 2.0% in the second quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock worth $527,000 after buying an additional 87 shares during the last quarter. UMB Bank n.a. increased its holdings in Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after buying an additional 88 shares during the last quarter. Inspire Investing LLC increased its holdings in Addus HomeCare by 3.3% in the third quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after buying an additional 100 shares during the last quarter. Finally, New York State Teachers Retirement System increased its holdings in Addus HomeCare by 1.2% in the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock worth $1,132,000 after buying an additional 100 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Wall Street Analysts Forecast Growth

ADUS has been the topic of a number of research reports. Oppenheimer increased their price objective on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. TD Cowen increased their price objective on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a research report on Thursday. KeyCorp assumed coverage on Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 target price for the company. Finally, Stephens upped their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $131.63.

Insider Activity

In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the transaction, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at $961,687.35. This trade represents a 75.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now directly owns 3,366 shares of the company’s stock, valued at approximately $429,165. This trade represents a 12.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 22,917 shares of company stock valued at $3,050,082. 4.60% of the stock is owned by company insiders.

Addus HomeCare Trading Down 1.9 %

ADUS opened at $119.78 on Friday. Addus HomeCare Co. has a 1-year low of $85.43 and a 1-year high of $136.12. The stock has a market capitalization of $2.17 billion, a price-to-earnings ratio of 27.41, a P/E/G ratio of 2.15 and a beta of 1.04. The business has a 50 day moving average of $128.99 and a 200-day moving average of $122.24.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. During the same period in the prior year, the business earned $1.03 earnings per share. Addus HomeCare’s revenue for the quarter was up 7.1% compared to the same quarter last year. Equities analysts predict that Addus HomeCare Co. will post 4.58 EPS for the current year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.